Challenges in Management of Febrile Infection-Related Epilepsy Syndrome: Real-World Experience From a Large Cohort of Pediatric Patients
- 21 January 2025
- journal article
- research article
- Published by Elsevier in Pediatric Neurology
- Vol. 165, 9-15
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- CSF neopterin and quinolinic acid are biomarkers of neuroinflammation and neurotoxicity in FIRES and other infection‐triggered encephalopathy syndromesAnnals of Clinical and Translational Neurology, 2023
- Isoflurane in (Super-) Refractory Status Epilepticus: A Multicenter EvaluationNeurocritical Care, 2021
- Intrathecal dexamethasone therapy for febrile infection‐related epilepsy syndromeAnnals of Clinical and Translational Neurology, 2021
- Anakinra usage in febrile infection related epilepsy syndrome: an international cohortAnnals of Clinical and Translational Neurology, 2020
- Proposal to optimize evaluation and treatment of Febrile infection‐related epilepsy syndrome (FIRES): A Report from FIRES workshopEpilepsia Open, 2020
- Functional deficiency in endogenous interleukin‐1 receptor antagonist in patients with febrile infection‐related epilepsy syndromeAnnals of Neurology, 2019
- Development of the clinical assessment scale in autoimmune encephalitisAnnals of Neurology, 2019
- Efficacy of Intravenous Midazolam for Status Epilepticus in ChildhoodPediatric Neurology, 2007
- High-dose midazolam therapy for refractory status epilepticus in childrenIntensive Care Medicine, 2006
- Treatment of Refractory Status Epilepticus With Inhalational Anesthetic Agents Isoflurane and DesfluraneArchives of Neurology, 2004